Actively Recruiting
GERD in Children With Cystic Fibrosis
Led by Duke University · Updated on 2025-12-19
20
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
Sponsors
D
Duke University
Lead Sponsor
C
Cystic Fibrosis Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
CONDITIONS
Official Title
GERD in Children With Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children 2-18 years of age with a confirmed CF diagnosis by either a positive sweat test or 2 disease causing CFTR mutations
- Signed consent
You will not qualify if you...
- Declining to participate in the study or sign consent
- History of severe GERD per gastroenterology diagnosis and documentation
- GSAS score >80
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Duke University Hospital
Durham, North Carolina, United States, 27710
Actively Recruiting
Research Team
Y
Yara Salameh, MF
CONTACT
S
Shatha Yousef, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here